Peripheral neuropathy is associated with increased mean platelet volume in type 2 diabetic patients [1]

Platelets

Volumn 16, Issue 8, 2005, Pages 498-499

  Papanas, N ^a,c   Mavridis, G ^b   Karavageli, E ^b   Symeonidis, G ^b   Maltezos, E ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b Aristotle University of Thessaloniki   (Greece)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; BLOOD SAMPLING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETINOPATHY; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME;

AGED; ALBUMINURIA; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT;

EID: 30944462758     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100500384723     Document Type: Letter

References (11)

1. Hekimsoy Z, Payzin B, Örnek T, Kandoǧan G. Mean platelet volume in Type 2 diabetic patients. J Diabetes Compl 2004;18:173-176.
2. Sharpe PC, Trinick T. Mean platelet volume in diabetes mellitus. Quart J Med 1993;86:739-742.
3. Papanas N, Symeonidis G, Maltezos E, Mavridis G, Karavageli E, Vosnakidis T, et al. Mean platelet volume in patients with type 2 diabetes mellitus. Platelets 2004;15:475-478.
4. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994;17:1281-1289.
5. Sima AAF. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci 2003;60:2445-2464.
6. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:183-197.
7. Papanas N, Papatheodorou K, Christakidis D, Papazoglou D, Giassakis G, Piperidou H, et al. Evaluation of a new indicator test for sudomotor function (Neuropad®) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp Clin Endocrinol Diabetes 2005;113:195-198.
8. O'Malley BC, Ward JD, Timperley WR, Porter NR, Preston FE. Platelet abnormalities in diabetic peripheral neuropathy. Lancet 1975;iv:1274-1276.
9. Jennings PE, Dallinger KJ, Nightingale S, Barnett AH. Abnormal platelet aggregation in chronic symptomatic diabetic peripheral neuropathy. Diabet Med 1986;3:237-240.
10. Hara T, Nakamura J, Koh N, Sakakibara F, Hamada Y, Sasaki H, et al. An aldose reductase inhibitor, TAT, reduces ADP-induced platelet hyperaggregation in streptozotocin-induced diabetic rats with neuropathy. J Lab Clin Med 1995;126:541-547.
11. Ueno Y, Koike H, Nakamura Y, Ochi Y, Annoh S, Nishio S. Effects of beraprost sodium, a prostacyclin analogue, on diabetic neuropathy in streptozotocin-induced diabetic rats. Jpn J Pharmacol 1996;70:177-182.